The Outcomes and Surgical Complications of Cats With Oral Squamous Cell Carcinoma Treated With Total Glosso-Mandibulectomy: 20 Cases (2008-2022)

被引:0
作者
Iwata, Taisuke [1 ]
Ichimata, Masanao [2 ]
Fujita, Atsushi [1 ]
Shiraishi, Yozo [1 ]
Kagawa, Yumiko [3 ]
Toshima, Atsushi [1 ]
Kobayashi, Tetsuya [2 ]
机构
[1] Japan Small Anim Med Ctr, Tokorozawa, Japan
[2] Japan Small Anim Med Ctr Fdn, Japan Small Anim Canc Ctr, Tokorozawa, Japan
[3] North Lab, Sapporo, Japan
关键词
cats; oral squamous cell carcinoma; surgery; total glosso-mandibulectomy; RADIATION-THERAPY; EFFICACY; RADIOTHERAPY; CARBOPLATIN; TOXICITY; PROTOCOL; TUMORS; DOGS;
D O I
10.1111/vco.13043
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Feline oral squamous cell carcinoma (FOSCC) is the most common oral malignancy in cats. In general, FOSCC develops rapidly and is highly locally invasive. The existing treatments for treating FOSCC are limited. The objective of this single-centre retrospective cohort study was to report the prognosis and surgical complications in cats that underwent total glosso-mandibulectomy (TGM) for feline oral squamous cell carcinoma (FOSCC). We investigated the medical records of 20 cats diagnosed with FOSCC by histopathologic examination and treated with TGM. The locations of FOSCC were in the mandible and tongue in 12 and 8 cats, respectively. All cats underwent percutaneous endoscopic gastrostomy. Postoperative complications of TGM were observed in 18 (90.0%) cats; incisional swelling was noted in 11 cats, including three cats with airway obstruction requiring management by tracheal intubation for several days. Postoperative anaemia was observed in 10 cats; two cats required blood transfusions. No cats died during the postoperative period. Progression-free interval (PFI) and overall survival time (OST) were 914 and 533 days, respectively. The 1- and 2-year survival rates were 50.2% and 37.8%, respectively. On univariate analysis, only histopathologic margin was associated with PFI and OST. TGM was successful in achieving long-term survival for FOSCC. Conversely, lifelong nutritional support via a gastrostomy tube and routine home care, including the removal of secretions from the palate and throat, was needed. There were no perioperative deaths, but serious complications occurred in some cats. The histopathologic margin was an important prognostic factor.
引用
收藏
页数:9
相关论文
共 24 条
  • [1] PERCUTANEOUS ENDOSCOPIC GASTROSTOMY - A RETROSPECTIVE STUDY OF 54 CLINICAL CASES IN DOGS AND CATS
    ARMSTRONG, PJ
    HARDIE, EM
    [J]. JOURNAL OF VETERINARY INTERNAL MEDICINE, 1990, 4 (04) : 202 - 206
  • [2] Feline Oral Squamous Cell Carcinoma: Clinical Manifestations and Literature Review
    Bilgic, Ozgur
    Duda, Lili
    Sanchez, Melissa D.
    Lewis, John R.
    [J]. JOURNAL OF VETERINARY DENTISTRY, 2015, 32 (01) : 30 - 40
  • [3] Outcomes of eight cats with oral neoplasia treated with radical mandibulectomy
    Boston, Sarah E.
    van Stee, Lucinda L.
    Bacon, Nicholas J.
    Szentimrey, David
    Kirby, Barbara M.
    van Nimwegen, Sebastiaan
    Wavreille, Vincent A.
    [J]. VETERINARY SURGERY, 2020, 49 (01) : 222 - 232
  • [4] Response of feline oral squamous cell carcinoma to palliative radiation therapy
    Bregazzi, VS
    LaRue, SP
    Powers, BE
    Fettman, MJ
    Ogilvie, GK
    Withrow, SJ
    [J]. VETERINARY RADIOLOGY & ULTRASOUND, 2001, 42 (01) : 77 - 79
  • [5] TECHNIQUE, PHARMACOKINETICS, TOXICITY, AND EFFICACY OF INTRATUMORAL ETANIDAZOLE AND RADIOTHERAPY FOR TREATMENT OF SPONTANEOUS FELINE ORAL SQUAMOUS-CELL CARCINOMA
    EVANS, SM
    LACRETA, F
    HELFAND, S
    VANWINKLE, T
    CURRAN, WJ
    BROWN, DQ
    HANKS, G
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 20 (04): : 703 - 708
  • [6] Treatment of Oral Squamous Cell Carcinoma with Accelerated Radiation Therapy and Concomitant Carboplatin in Cats
    Fidel, J.
    Lyons, J.
    Tripp, C.
    Houston, R.
    Wheeler, B.
    Ruiz, A.
    [J]. JOURNAL OF VETERINARY INTERNAL MEDICINE, 2011, 25 (03) : 504 - 510
  • [7] A nine-day accelerated radiation protocol for feline squamous cell carcinoma
    Fidel, Janean L.
    Sellon, Rance K.
    Houston, Robert K.
    Wheeler, Betsy A.
    [J]. VETERINARY RADIOLOGY & ULTRASOUND, 2007, 48 (05) : 482 - 485
  • [8] Use of cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II), a liposomal cisplatin analogue, in cats with oral squamous cell carcinoma
    Fox, LE
    Rosenthal, RC
    King, RR
    Levine, PB
    Vail, DM
    Helfand, SC
    MacEwen, EG
    Perez-Soler, R
    Calderwood-Mays, M
    Kurzman, ID
    [J]. AMERICAN JOURNAL OF VETERINARY RESEARCH, 2000, 61 (07) : 791 - 795
  • [9] Gemcitabine as a radiosensitizer for nonresectable feline oral squamous cell carcinoma
    Jones, PD
    de Lorimier, LP
    Kitchell, BE
    Losonsky, JM
    [J]. JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION, 2003, 39 (05) : 463 - 467
  • [10] Phase I clinical evaluation of carboplatin in tumor-bearing cats: A veterinary cooperative oncology group study
    Kisseberth, W. C.
    Vail, D. M.
    Yaissle, J.
    Jeglum, K. A.
    Couto, C. G.
    Ward, H.
    Khanna, C.
    Obradovich, J. E.
    [J]. JOURNAL OF VETERINARY INTERNAL MEDICINE, 2008, 22 (01) : 83 - 88